Overview
- 85 inspections across 83 sites are on record.
- 252 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-20.
At a glance
Inspections
85
Sites
83
Observations
252
Career since
Sep 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Strides Pharma Science Limited | 20 May 2026 | Human Drugs | On file |
| USV Private Limited | 17 Apr 2026 | Human Drugs | On file |
| Acme Generics Private Limited | 20 Feb 2026 | Human Drugs | View 483 → |
| Dabur India Limited | 16 Jan 2026 | Human Drugs | View 483 → |
| APL HEALTHCARE LIMITED | 17 Dec 2025 | Human Drugs | View 483 → |
Sites inspected
Strides Pharma Science LimitedBangalore, India1 insp.
USV Private LimitedDabhel, Daman, India1 insp.
Acme Generics Private LimitedSolan, India1 insp.
Dabur India LimitedDadra And Nagar Haveli, India1 insp.
APL HEALTHCARE LIMITEDNaidupeta, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Lisa L Flores7 shared
Logan T Williams5 shared
Wen Ning Chan5 shared
Martin M Kimani3 shared
Paranthaman SenthamaraiKannan3 shared
Jacob G Lutz2 shared
Saleem A Akhtar2 shared
Guerlain Ulysse2 shared
Robert J Ham2 shared
Joseph A Piechocki2 shared
Full investigator report
Get the verbatim findings behind Rafeeq A Habeeb's 252 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site